# FDA Inspection 1246222 - Danville Regional Medical Center - July 30, 2024

Source: https://www.keypedia.com/records/fda_inspections/danville-regional-medical-center/955dfdbc-0ccb-4cef-89a5-1981fa27dfdc
Source feed: FDA_Inspections

> FDA Inspection 1246222 for Danville Regional Medical Center on July 30, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1246222
- Company Name: Danville Regional Medical Center
- Inspection Date: 2024-07-30
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1090102 - 2019-04-25](https://www.keypedia.com/records/fda_inspections/danville-regional-medical-center/f160ffce-1ce4-40bc-a297-4010e2363786)

Company: https://www.keypedia.com/companies/danville-regional-medical-center/de4b0616-bb72-4419-a44e-b429b49d02ad

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d